Phenazolam 250 UG

Phenazolam 250 ug Blotters Ultra-Potent Research Compound for Precision Study

Phenazolam 250 ug Blotters contain Phenazolam, a highly potent benzodiazepine analog known for its strong sedative and calming properties. While not approved for therapeutic use, Phenazolam is researched for its rapid onset, high receptor affinity, and pronounced central nervous system (CNS) depressant action. Each blotter delivers an exact microgram-level dose, making it suitable only for advanced research applications and highly experienced handling.

Key Features:

• Each blotter contains 250 ug of Phenazolam

• Extremely potent benzodiazepine analog with sedative, muscle relaxant, and hypnotic properties

• Rapid onset and long-lasting effects

• Investigated in laboratory settings for its receptor activity and potency profile

• Not approved for human or veterinary use research purposes only

How Phenazolam 250 ug Works:

Phenazolam functions as a GABA_A receptor positive allosteric modulator, similar to other benzodiazepines:

• Enhances the action of gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter

• Reduces neural excitability, producing sedation, muscle relaxation, and calmness

• Onset is typically rapid, with effects lasting several hours

• Due to its extreme potency, microgram-level dosing requires exceptional precision and careful control

Commonly Researched For:

• Comparative potency studies of benzodiazepine analogs

• Duration of action and receptor binding affinity analysis

• Structure–activity relationship (SAR) investigations

• Risk assessment studies related to high-potency sedatives

Usage Instructions:

• Sublingual blotter placement is the most common administration in controlled research settings

• Do not chew or swallow for optimal absorption profile

• Even slight dose miscalculations can result in profound effects – start with the lowest feasible amount for research

• Avoid redosing within the same session due to the risk of cumulative effects

Important Safety Information:

• Not approved by FDA/EMA for consumption – strictly for laboratory research only

• Extremely high potency – misuse can lead to severe sedation, respiratory depression, or fatality

• Dangerous interactions with alcohol, opioids, or other CNS depressants

• May cause memory impairment, loss of coordination, and blackouts

• Must be stored securely away from unauthorized access, children, and pets

Possible Side Effects (Observed in Related Compounds):

• Sedation and drowsiness

• Short-term memory issues

• Impaired coordination or balance

• Slurred speech

• Emotional flattening

Serious risks:

• Respiratory depression

• Complete loss of consciousness

• Physical dependence and withdrawal on repeated exposure

• Overdose potential even at microgram levels

Why Choose Phenazolam 250 ug Blotters?

Phenazolam 250 ug Blotters provide researchers with an ultra-potent, precisely measured format ideal for studying high-affinity benzodiazepine analogs. The microgram dose format allows accurate, consistent delivery for controlled experiments, making it suitable only for professional, well-equipped laboratory environments where precision and safety are top priorities.